CHPT three-lens brief
Evidence-based stock research on CHPT. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Outperforming SPY by 11.1pp over 30 days. · Trading at 15% of its 52-week range — deep in the lower band.
- Trading at 15% of its 52-week range — deep in the lower band.
- Outperforming SPY by 11.1pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Debt-to-equity of 1297.8 — balance-sheet-heavy.
CHPT closed at $6.40 (+0.16%) as of 2026-05-04. Market cap: $156.26M. Positives: outperforming SPY by 11.1pp over 30 days.. Concerns: trading at 15% of its 52-week range — deep in the lower band.; currently unprofitable on a trailing basis — no P/E multiple available.. Last quarter: Revenue $109.32M, net income -$44.42M, free cash flow $23.36M.
Why three lenses on CHPT, not one.
A single reasoning model has blind spots it doesn’t know about. We examine CHPTacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/CHPT" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath CHPT brief"></iframe>